Cautionary optimism: caffeine and Parkinson's disease risk
Leonard L Sokol1, Michael J Young2, Alberto J Espay1
1Department of Neurology, James J and Joan A. Gardner Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Cincinnati, OH USA.
Journal of Clinical Movement Disorders
|June 9, 2016
Summary
Caffeine may reduce Parkinson's disease (PD) risk in individuals with a specific genetic mutation (LRRK2 R1628P). This finding offers potential preventative strategies for at-risk family members of PD patients.
Area of Science:
- Neuroscience
- Genetics
- Preventative Medicine
Background:
- Most Parkinson's disease (PD) cases lack a family history or clear prodromal phase, complicating primary and secondary prevention efforts.
- Monogenic forms of PD offer a window for intervention in gene-carrying family members through lifestyle modifications.
- The absence of established disease-modifying treatments has historically limited preventive recommendations for at-risk populations.
Purpose of the Study:
- To investigate the association between caffeine consumption and the risk of developing Parkinson's disease (PD).
- To explore potential preventative measures for individuals carrying the LRRK2 R1628P mutation, a known genetic risk factor for PD.
Main Methods:
- Retrospective analysis of caffeine consumption patterns.
- Examination of PD risk within a cohort of individuals with the LRRK2 R1628P mutation.
Main Results:
- Preliminary analysis suggests a potential inverse relationship between caffeine intake and PD risk in the LRRK2 R1628P cohort.
- This study is the first to examine caffeine's role in PD risk within this specific genetic subgroup.
Conclusions:
- Caffeine consumption may represent a modifiable factor influencing PD risk in individuals with the LRRK2 R1628P mutation.
- Further research is warranted to confirm these findings and explore the underlying mechanisms for potential therapeutic or preventative applications.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:29Stimulants
1.2K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.2K
01:37Neural Regulation
44.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.2K
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
440
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
440
01:13Insufficient Sleep and Sleep Deprivation
1.2K
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
1.2K